Standard Uncoated Balloon Angioplasty Catheter

DEVICE3 trials

Conditions

ArteriosclerosisAtherosclerosisFemoral Arterial StenosisFemoral Artery OcclusionFemoral Artery StenosisOcclusion of Popliteal ArteriesRestenosisStenosis of Popliteal Arteries

Phase 1

LEVANT I, The Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis

CompletedNCT00930813

C. R. BardArteriosclerosis, Atherosclerosis, Vascular Disease

Start: 2009-06-30End: 2011-12-31Updated: 2015-12-21

Phase 2

LEVANT Japan Clinical Trial

CompletedNCT01816412

C. R. BardFemoral Arterial Stenosis, Femoral Artery Occlusion, Occlusion of Popliteal Arteries +1

Start: 2013-03-31End: 2016-06-30Updated: 2016-09-28

Unknown Phase

Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

CompletedNCT02063672

C. R. BardFemoral Artery Occlusion, Femoral Artery Stenosis, Restenosis

Start: 2014-03-31End: 2019-03-31Updated: 2019-04-11

Related Papers

Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease

JACC: Cardiovascular Interventions2019-09-2890 citations

The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.